Increased integral bone mineral density (BMD) of the hip with once-yearly zoledronic acid 5 mg (ZOL): Quantitative computed tomography data (QCT) from the horizon-pft trial

被引：0

作者：

Eastell, R. ^{[1
]}

Lang, T. ^{[2
]}

Boonen, S. ^{[3
,4
]}

Cummings, S. ^{[5
]}

Delmas, P. D. ^{[6
]}

Cauley, J. ^{[7
]}

Horowitz, Z. ^{[8
]}

Kerzberg, E. ^{[9
]}

Leung, P. ^{[10
]}

Man, Z. ^{[11
]}

Mesenbrink, P. ^{[12
]}

Eriksen, E. F. ^{[13
]}

Black, D. ^{[14
]}

机构：

[1] Univ Sheffield, Dept Human Metab & Clin Biochem, Sheffield, S Yorkshire, England

[2] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA

[3] Leuven Univ, Ctr Metab Bone Dis, Leuven, Belgium

[4] Katholieke Univ Leuven, Div Geriatr Med, Leuven, Belgium

[5] Univ Calif San Francisco, Res Inst, CPMC, San Francisco, CA 94143 USA

[6] Univ Lyon, INSERM, Res Unit 831, Lyon, France

[7] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA

[8] Savient Pharmaceut, E Brunswick, NJ 08816 USA

[9] Hosp Ramos Mejia, Argentine Reference Ctr Osteoporosis, Buenos Aires, DF, Argentina

[10] Chinese Univ Hong Kong, Fac Med, Hong Kong, Hong Kong, Peoples R China

[11] Univ Favaloro, Ctr TIEMPO, Buenos Aires, DF, Argentina

[12] Novartis Pharmaceut Corp, Dept Biostat, E Hanover, NJ 07936 USA

[13] Novartis Pharma AG, Basel, Switzerland

[14] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA

来源：

CALCIFIED TISSUE INTERNATIONAL | 2008年 / 82卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S54 / S55

页数：2

共 22 条

[1] Effect of Once-Yearly Zoledronic Acid on Integral Bone Mineral Density of the Spine: Quantitative Computed Tomography, Results of HORIZON-PFT.
Eastell, R.
Lang, T.
Boonen, S.
Cummings, S. R.
Delmas, P. D.
Cauley, J. A.
Horowitz, Z.
Kerzberg, E.
Bianchi, G.
Kendler, D.
Leung, P.
Man, Z.
Mesenbrink, P.
Eriksen, E. F.
Black, D. M.
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S345 - S345
[2] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: data from HORIZON-PFT
Delmas, P. D.
Bauer, D.
Black, D.
Boonen, S.
Cosman, F.
Eastell, R.
[J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S130 - S131
[3] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-PFT
Delmas, P. D.
Bauer, D.
Black, D.
Boonen, S. R.
Cosman, F.
Eastell, R.
[J]. CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S29 - S29
[4] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-PFT
Delmas, Pierre
Bauer, Douglas
Black, Dennis
Boonen, Steven R.
Cosman, Felicia
Eastell, Richard
[J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S214 - S215
[5] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-pft
Delmas, P.
Bauer, D.
Black, D.
Boonen, S.
Cosman, F.
Eriksen, E. F.
Mesenbrink, R.
Eastell, R.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 523 - 523
[6] Bone Mineral Density (BMD) After Hip Fracture: Variations in Response to Once-Yearly i.v. Zoledronic acid (ZOL) 5 mg
Magaziner, J.
Orwig, D.
Lyles, K. W.
Nordsletten, L.
Boonen, S.
Adachi, J.
Colon-Emeric, C.
Bucci-Rechtweg, C.
Mesenbrink, P.
Pieper, C.
[J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 : S86 - S86
[7] Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: Results from horizon-PFT
Black, D.
Delmas, P.
Eastell, R.
Reid, I.
Boonen, S.
Cauley, J.
Cosman, F.
Lakatos, R.
Leung, P. C.
Man, Z.
Eriksen, E. F.
Mesenbrink, P.
Hue, T.
Cummings, S.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 101 - 101
[8] Renal safety of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: Results from horizon-PFT
Miller, P.
Delmas, R.
Sellmeyer, D.
Abrams, K.
Hu, H.
Lippuner, K.
Boonen, S.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 523 - 524
[9] Renal safety of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: Results from horizon-PFT
Miller, Paul
Sellmeyer, Deborah
Boonen, Steven R.
[J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S227 - S228
[10] Renal safety of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: results from HORIZON-PFT
Miller, P.
Sellmeyer, D.
Boonen, S.
[J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S129 - S130

← 1 2 3 →